Buchumschlag

Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli‐D Study

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Xiaohong Wu, Ying Zhang, Ziling Li, Agustina Alvarez, Felipe Lauand, Lydie Melas‐Melt, Minlu Zhang, Lei Kang, Qin Du, Jie Zhang, Yiming Mu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Journal of Diabetes
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study
von: Weijun Gu, et al.
Veröffentlicht: (2025)

Evaluation of efficacy of iGlarLixi versus IDegAsp using derived time‐in‐ranges in Chinese adults with Type 2 diabetes: A post hoc analysis of the Soli‐D study
von: Juan Liu, et al.
Veröffentlicht: (2025)

The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
von: Ming Liu, et al.
Veröffentlicht: (2024)

Time‐in‐range derived from self‐measured blood glucose in people with type 2 diabetes advancing to iGlarLixi : A participant‐level pooled analysis of three phase 3 LixiLan randomized controlled trials
von: Martin Haluzík, et al.
Veröffentlicht: (2024)

Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes: The Soli‐ SWITCH study
von: Martin Haluzík, et al.
Veröffentlicht: (2025)

Long‐term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli‐durability 24‐month observational study
von: Rayaz A. Malik, et al.
Veröffentlicht: (2025)

Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials
von: Wenying Yang, et al.
Veröffentlicht: (2024)

Safety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico
von: Juan Rosas‐Guzman, et al.
Veröffentlicht: (2025)

Insulin therapy DE ‐ intensificAtion with iGlarLixi : A phase 4, open‐label, parallel‐group randomised controlled trial
von: Peter Novodvorský, et al.
Veröffentlicht: (2025)

Improved glycaemic control in people with type 2 diabetes initiating or switching to IDegAsp in a real‐world setting in China
von: Lixin Guo, et al.
Veröffentlicht: (2024)

Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes
von: Juan P. Frías, et al.
Veröffentlicht: (2025)

Efficacy and safety of switching to iGlarLixi from premixed insulin therapy in patients with type 2 diabetes: A real‐world experience
von: Chun‐Jui Huang, et al.
Veröffentlicht: (2026)

Real‐life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use
von: Jochen Seufert, et al.
Veröffentlicht: (2024)

iGlarLixi : A titrateable fixed‐ratio combination of basal insulin + GLP‐1 receptor agonist—An effective type 2 diabetes treatment option in China
von: Miao Yu
Veröffentlicht: (2025)

The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
von: Yiming Mu
Veröffentlicht: (2024)

Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial
von: Shujing Wu, et al.
Veröffentlicht: (2025)

Association of TLR4 polymorphisms (Asp299Gly and Thr399Ile) with sepsis: a meta‐analysis and trial sequence analysis
von: Jingjing Mu, et al.
Veröffentlicht: (2024)

Tomás de Aquino: filosofia e pedagogia
von: Jean Lauand
Veröffentlicht: (2012)

Tomás de Aquino, Anselmo de Canterbury e a crítica da razão teológica
von: Jean Lauand
Veröffentlicht: (2010)

PostHoc FREE Calibrating on Kolmogorov Arnold Networks
von: Liang, Wenhao, et al.
Veröffentlicht: (2025)

Mathematical Insights into Glycemic Regulation in Type-I Diabetes
von: Emily J. Wynter, et al.
Veröffentlicht: (2024)

Optimal Post-Hoc Theorizing
von: Chen, Andrew Y.
Veröffentlicht: (2025)

Type 2 Diabetes, Glycemic Traits and Overall Cancer Risk: A Large‐Scale Prospective Cohort Study
von: Aiping Zhang, et al.
Veröffentlicht: (2026)

La tontería y los tontos en el Análisis de Tomás de Aquino
von: L. Jean Lauand
Veröffentlicht: (2002)

Glycemic Variability and Gut Microbiota Metabolic Patterns: A Novel Perspective on Diabetic Complications
von: Yongjie Xu, et al.
Veröffentlicht: (2025)

Chapter 13 Pulmonary Diseases and Traditional Chinese Medicine
von: Zhao, Baochang, et al.
Veröffentlicht: (2024)

Decomposition-Enhanced Training for Post-Hoc Attributions In Language Models
von: Balasubramanian, Sriram, et al.
Veröffentlicht: (2025)

Post-Hoc Calibrated Anomaly Detection
von: Gloumeau, Sean
Veröffentlicht: (2025)

The Impact of Expanding Diabetes Services on the Trend of Glycemic Control in Children and Adolescents with Type 1 Diabetes
von: Nouf Alissa, et al.
Veröffentlicht: (2024)

Glycemic Control and Fracture Risk in Patients With Type 2 Diabetes Mellitus
von: Shiuan‐Tzuen Su, et al.
Veröffentlicht: (2025)

The Value of Glycemic Gap for Predicting Mortality in ICU in Patients With and Without Diabetes
von: Ran Lou, et al.
Veröffentlicht: (2025)

The Effect of Diabetes Mellitus and Glycemic Parameters on the Prognosis of COVID‐19 Disease
von: Işılay Kalan Sarı, et al.
Veröffentlicht: (2025)

ARC-STAR: Auditable Post-Hoc Correction for PDE Foundation Models
von: Li, Chengze, et al.
Veröffentlicht: (2026)

Enhancing Glycemic Risk Assessment in Long‐Term Care: Suggestions for Future Research
von: Zhen Xu, et al.
Veröffentlicht: (2025)

The Effect of HBV Therapy on Glycemic Control in HBV‐Infected Patients With Diabetes: A 90‐day Multicenter Study
von: Qi Liu, et al.
Veröffentlicht: (2025)

A herança transgeracional nos transtornos alimentares: algumas reflexões
von: Christiane Baldin Adami-Lauand
Veröffentlicht: (2011)

Evaluation of Diabetes Self‐Care Activities and Glycemic Control Profiles in People With Type 2 Diabetes Mellitus
von: Sonu Neupane, et al.
Veröffentlicht: (2026)

Patient Activation and Diabetes Outcomes Among Jordanian Patients With Type 2 Diabetes: Longitudinal Evidence on Adherence and Glycemic Control With Linear Mixed Model Analysis
von: Mohammad R. Alosta, et al.
Veröffentlicht: (2026)

B9 Post Hoc Justification Is Impossible
von: Maley, Amos
Veröffentlicht: (2026)

Post-Hoc Large-Sample Statistical Inference
von: Chugg, Ben, et al.
Veröffentlicht: (2026)